Instil Bio, Inc. Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent
Instil Bio, Inc. (TIL) reported Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent of 4.40% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate · last filed 2025-03-04
- Instil Bio, Inc. effective income tax rate reconciliation, change in enacted tax rate, percent for fiscal 2024 was 4.40%, a 29.41% increase from fiscal 2023.
- Instil Bio, Inc. effective income tax rate reconciliation, change in enacted tax rate, percent for fiscal 2023 was 3.40%, a 209.09% increase from fiscal 2022.
- Instil Bio, Inc. effective income tax rate reconciliation, change in enacted tax rate, percent for fiscal 2022 was 1.10%, a 59.26% decline from fiscal 2021.
- Instil Bio, Inc. effective income tax rate reconciliation, change in enacted tax rate, percent for fiscal 2021 was 2.70%, a 2600.00% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent 12 month |
|---|---|
| 2024-12-31 | 4.40% 10-K · filed 2025-03-04 |
| 2023-12-31 | 3.40% 10-K · filed 2025-03-04 |
| 2022-12-31 | 1.10% 10-K · filed 2024-03-21 |
| 2021-12-31 | 2.70% 10-K · filed 2023-03-31 |
| 2020-12-31 | 0.10% 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |